Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort ascending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort ascending Date Posted
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Oct 15, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 15, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Oct 16, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 16, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Czech Republic Finance CTS Audit & Finance Oct 17, 2024
Financial IT Compliance Manager London (The Westworks) Czech Republic Finance CTS Audit & Finance Oct 17, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 17, 2024
Data Analyst, Digital Finance Hyderabad (Office) India Operations Innovative Medicines Audit & Finance Oct 18, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Director HSPD Asset Lead and Expert London (The Westworks) Switzerland International Innovative Medicines Marketing Sep 03, 2024
Director, Process Effectiveness & Reporting East Hanover USA US Innovative Medicines Marketing Sep 03, 2024
Brand Manager Oncology Bucuresti Romania International Innovative Medicines Marketing Aug 21, 2024
Manager - Field Effectiveness Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
Field Force Execution Lead (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Sep 19, 2024
Head of Data Driven Decision Making New South Wales (NSW) Australia International Innovative Medicines Marketing Sep 19, 2024
Digital Strategy & Insights Manager (f/m/d) Vienna Austria International Innovative Medicines Marketing Sep 20, 2024
Brand manager - Oncology (m/f/d) / Vodja blagovne znamke v onkologiji (m/ž/d) Ljubljana Slovenia International Innovative Medicines Marketing Sep 20, 2024
Strategy Manager Taipei Taiwan International Innovative Medicines Marketing Jul 24, 2024
Team Leader Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
Customer Experience Manager ST Bucuresti Romania International Innovative Medicines Marketing Jul 31, 2024
Director- Data Science Hyderabad (Office) India Operations CTS Marketing Oct 03, 2024
Data Steward Hyderabad (Office) India Operations CTS Marketing Oct 09, 2024
Associate Director, Digital Analytics - HQ based - East Hanover, NJ East Hanover USA US Innovative Medicines Marketing Oct 09, 2024
Director, Marketing & Digital Data Solution Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Director Data Stratagy Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Executive Director, Product Strategy Lead East Hanover USA US Innovative Medicines Marketing Oct 02, 2024
Customer Insights & Product Manager - Neurology & Immunology Warsaw Poland International Innovative Medicines Marketing Oct 07, 2024
Content & Education Specialist Hyderabad (Office) India Operations CTS Marketing Oct 07, 2024
Brand & Customer Manager Prague Czech Republic International Innovative Medicines Marketing Oct 08, 2024
Launch Excellence Strategy Manager Taipei Taiwan International Innovative Medicines Marketing Oct 08, 2024
Senior Analyst, Product Management Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Innovation & Business Excellence Project Manager Milano Italy International Innovative Medicines Marketing Oct 08, 2024
Integrated Business Insight Manager Milano Italy International Innovative Medicines Marketing Oct 11, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only